MYLERAN

This brand name is authorized in Austria, Australia, Canada, Estonia, France, Hong Kong, Ireland, Israel, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Tunisia, United States

Active ingredients

The drug MYLERAN contains one active pharmaceutical ingredient (API):

1 Busulfan UNII G1LN9045DK - BUSULFAN

Busulfan is a potent cytotoxic agent and a bifunctional alkylating agent. In aqueous media, release of the methanesulphonate groups produces carbonium ions which can alkylate DNA, thought to be an important biological mechanism for its cytotoxic effect. Read about Busulfan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MYLERAN Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01AB01	Busulfan	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AB Alkyl sulfonates
Discover more medicines within L01AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1128J
Country: CA	Health Products and Food Branch	Identifier(s): 00004618
Country: EE	Ravimiamet	Identifier(s): 1005006
Country: FR	Base de données publique des médicaments	Identifier(s): 64700734
Country: HK	Department of Health Drug Office	Identifier(s): 03799
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4404
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1001323
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 50871
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 1872
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 2763
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100045175
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W58856001, W58856002
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 1233011
Country: US	FDA, National Drug Code	Identifier(s): 76388-713